- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Tuberculosis (TB) Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Tuberculosis (TB) Diagnostics market size is estimated to be worth US$ 2706.1 million in 2021 and is forecast to a readjusted size of USD 3635.2 million by 2028 with a CAGR of 4.3% during review period. Diagnostic Laboratories accounting for % of the Tuberculosis (TB) Diagnostics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Culture-Based Diagnostics segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Tuberculosis (TB) Diagnostics include Danaher, Roche, Thermo Fisher Scientific, BD, and Abbott, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Tuberculosis (TB) Diagnostics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Market segment by Application, can be divided into
Diagnostic Laboratories
Hospitals
Market segment by players, this report covers
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Tuberculosis (TB) Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Tuberculosis (TB) Diagnostics, with revenue, gross margin and global market share of Tuberculosis (TB) Diagnostics from 2019 to 2022.
Chapter 3, the Tuberculosis (TB) Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Tuberculosis (TB) Diagnostics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Tuberculosis (TB) Diagnostics research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Tuberculosis (TB) Diagnostics
1.2 Classification of Tuberculosis (TB) Diagnostics by Type
1.2.1 Overview: Global Tuberculosis (TB) Diagnostics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type in 2021
1.2.3 Culture-Based Diagnostics
1.2.4 Sputum Smear Microscopy
1.2.5 Rapid Molecular Diagnostics
1.2.6 Others
1.3 Global Tuberculosis (TB) Diagnostics Market by Application
1.3.1 Overview: Global Tuberculosis (TB) Diagnostics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Global Tuberculosis (TB) Diagnostics Market Size & Forecast
1.5 Global Tuberculosis (TB) Diagnostics Market Size and Forecast by Region
1.5.1 Global Tuberculosis (TB) Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Tuberculosis (TB) Diagnostics Market Size by Region, (2017-2022)
1.5.3 North America Tuberculosis (TB) Diagnostics Market Size and Prospect (2017-2028)
1.5.4 Europe Tuberculosis (TB) Diagnostics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size and Prospect (2017-2028)
1.5.6 South America Tuberculosis (TB) Diagnostics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Tuberculosis (TB) Diagnostics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Tuberculosis (TB) Diagnostics Market Drivers
1.6.2 Tuberculosis (TB) Diagnostics Market Restraints
1.6.3 Tuberculosis (TB) Diagnostics Trends Analysis
2 Company Profiles
2.1 Danaher
2.1.1 Danaher Details
2.1.2 Danaher Major Business
2.1.3 Danaher Tuberculosis (TB) Diagnostics Product and Solutions
2.1.4 Danaher Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Danaher Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Tuberculosis (TB) Diagnostics Product and Solutions
2.2.4 Roche Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Roche Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product and Solutions
2.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 BD
2.4.1 BD Details
2.4.2 BD Major Business
2.4.3 BD Tuberculosis (TB) Diagnostics Product and Solutions
2.4.4 BD Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 BD Recent Developments and Future Plans
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Tuberculosis (TB) Diagnostics Product and Solutions
2.5.4 Abbott Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Abbott Recent Developments and Future Plans
2.6 Hologic
2.6.1 Hologic Details
2.6.2 Hologic Major Business
2.6.3 Hologic Tuberculosis (TB) Diagnostics Product and Solutions
2.6.4 Hologic Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Hologic Recent Developments and Future Plans
2.7 Qiagen
2.7.1 Qiagen Details
2.7.2 Qiagen Major Business
2.7.3 Qiagen Tuberculosis (TB) Diagnostics Product and Solutions
2.7.4 Qiagen Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Qiagen Recent Developments and Future Plans
2.8 BioMerieux
2.8.1 BioMerieux Details
2.8.2 BioMerieux Major Business
2.8.3 BioMerieux Tuberculosis (TB) Diagnostics Product and Solutions
2.8.4 BioMerieux Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 BioMerieux Recent Developments and Future Plans
2.9 Hain Lifescience
2.9.1 Hain Lifescience Details
2.9.2 Hain Lifescience Major Business
2.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Product and Solutions
2.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Hain Lifescience Recent Developments and Future Plans
2.10 Oxford Immunotec
2.10.1 Oxford Immunotec Details
2.10.2 Oxford Immunotec Major Business
2.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Product and Solutions
2.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Oxford Immunotec Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Tuberculosis (TB) Diagnostics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Tuberculosis (TB) Diagnostics Players Market Share in 2021
3.2.2 Top 10 Tuberculosis (TB) Diagnostics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Tuberculosis (TB) Diagnostics Players Head Office, Products and Services Provided
3.4 Tuberculosis (TB) Diagnostics Mergers & Acquisitions
3.5 Tuberculosis (TB) Diagnostics New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Tuberculosis (TB) Diagnostics Revenue and Market Share by Type (2017-2022)
4.2 Global Tuberculosis (TB) Diagnostics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2017-2022)
5.2 Global Tuberculosis (TB) Diagnostics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Tuberculosis (TB) Diagnostics Revenue by Type (2017-2028)
6.2 North America Tuberculosis (TB) Diagnostics Revenue by Application (2017-2028)
6.3 North America Tuberculosis (TB) Diagnostics Market Size by Country
6.3.1 North America Tuberculosis (TB) Diagnostics Revenue by Country (2017-2028)
6.3.2 United States Tuberculosis (TB) Diagnostics Market Size and Forecast (2017-2028)
6.3.3 Canada Tuberculosis (TB) Diagnostics Market Size and Forecast (2017-2028)
6.3.4 Mexico Tuberculosis (TB) Diagnostics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Tuberculosis (TB) Diagnostics Revenue by Type (2017-2028)
7.2 Europe Tuberculosis (TB) Diagnostics Revenue by Application (2017-2028)
7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Country
7.3.1 Europe Tuberculosis (TB) Diagnostics Revenue by Country (2017-2028)
7.3.2 Germany Tuberculosis (TB) Diagnostics Market Size and Forecast (2017-2028)
7.3.3 France Tuberculosis (TB) Diagnostics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Tuberculosis (TB) Diagnostics Market Size and Forecast (2017-2028)
7.3.5 Russia Tuberculosis (TB) Diagnostics Market Size and Forecast (2017-2028)
7.3.6 Italy Tuberculosis (TB) Diagnostics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Type (2017-2028)
8.2 Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Application (2017-2028)
8.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region
8.3.1 Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Region (2017-2028)
8.3.2 China Tuberculosis (TB) Diagnostics Market Size and Forecast (2017-2028)
8.3.3 Japan Tuberculosis (TB) Diagnostics Market Size and Forecast (2017-2028)
8.3.4 South Korea Tuberculosis (TB) Diagnostics Market Size and Forecast (2017-2028)
8.3.5 India Tuberculosis (TB) Diagnostics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Tuberculosis (TB) Diagnostics Market Size and Forecast (2017-2028)
8.3.7 Australia Tuberculosis (TB) Diagnostics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Tuberculosis (TB) Diagnostics Revenue by Type (2017-2028)
9.2 South America Tuberculosis (TB) Diagnostics Revenue by Application (2017-2028)
9.3 South America Tuberculosis (TB) Diagnostics Market Size by Country
9.3.1 South America Tuberculosis (TB) Diagnostics Revenue by Country (2017-2028)
9.3.2 Brazil Tuberculosis (TB) Diagnostics Market Size and Forecast (2017-2028)
9.3.3 Argentina Tuberculosis (TB) Diagnostics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Type (2017-2028)
10.2 Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Application (2017-2028)
10.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country
10.3.1 Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Country (2017-2028)
10.3.2 Turkey Tuberculosis (TB) Diagnostics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Tuberculosis (TB) Diagnostics Market Size and Forecast (2017-2028)
10.3.4 UAE Tuberculosis (TB) Diagnostics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Tuberculosis (TB) Diagnostics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Tuberculosis (TB) Diagnostics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Tuberculosis (TB) Diagnostics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Tuberculosis (TB) Diagnostics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2023-2028)
Table 6. Danaher Corporate Information, Head Office, and Major Competitors
Table 7. Danaher Major Business
Table 8. Danaher Tuberculosis (TB) Diagnostics Product and Solutions
Table 9. Danaher Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Roche Corporate Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Tuberculosis (TB) Diagnostics Product and Solutions
Table 13. Roche Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 15. Thermo Fisher Scientific Major Business
Table 16. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product and Solutions
Table 17. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. BD Corporate Information, Head Office, and Major Competitors
Table 19. BD Major Business
Table 20. BD Tuberculosis (TB) Diagnostics Product and Solutions
Table 21. BD Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Abbott Corporate Information, Head Office, and Major Competitors
Table 23. Abbott Major Business
Table 24. Abbott Tuberculosis (TB) Diagnostics Product and Solutions
Table 25. Abbott Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Hologic Corporate Information, Head Office, and Major Competitors
Table 27. Hologic Major Business
Table 28. Hologic Tuberculosis (TB) Diagnostics Product and Solutions
Table 29. Hologic Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Qiagen Corporate Information, Head Office, and Major Competitors
Table 31. Qiagen Major Business
Table 32. Qiagen Tuberculosis (TB) Diagnostics Product and Solutions
Table 33. Qiagen Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. BioMerieux Corporate Information, Head Office, and Major Competitors
Table 35. BioMerieux Major Business
Table 36. BioMerieux Tuberculosis (TB) Diagnostics Product and Solutions
Table 37. BioMerieux Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Hain Lifescience Corporate Information, Head Office, and Major Competitors
Table 39. Hain Lifescience Major Business
Table 40. Hain Lifescience Tuberculosis (TB) Diagnostics Product and Solutions
Table 41. Hain Lifescience Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Oxford Immunotec Corporate Information, Head Office, and Major Competitors
Table 43. Oxford Immunotec Major Business
Table 44. Oxford Immunotec Tuberculosis (TB) Diagnostics Product and Solutions
Table 45. Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Tuberculosis (TB) Diagnostics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Tuberculosis (TB) Diagnostics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Tuberculosis (TB) Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Tuberculosis (TB) Diagnostics Players Head Office, Products and Services Provided
Table 50. Tuberculosis (TB) Diagnostics Mergers & Acquisitions in the Past Five Years
Table 51. Tuberculosis (TB) Diagnostics New Entrants and Expansion Plans
Table 52. Global Tuberculosis (TB) Diagnostics Revenue (USD Million) by Type (2017-2022)
Table 53. Global Tuberculosis (TB) Diagnostics Revenue Share by Type (2017-2022)
Table 54. Global Tuberculosis (TB) Diagnostics Revenue Forecast by Type (2023-2028)
Table 55. Global Tuberculosis (TB) Diagnostics Revenue by Application (2017-2022)
Table 56. Global Tuberculosis (TB) Diagnostics Revenue Forecast by Application (2023-2028)
Table 57. North America Tuberculosis (TB) Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Tuberculosis (TB) Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Tuberculosis (TB) Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Tuberculosis (TB) Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Tuberculosis (TB) Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Tuberculosis (TB) Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Tuberculosis (TB) Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Tuberculosis (TB) Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Tuberculosis (TB) Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Tuberculosis (TB) Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Tuberculosis (TB) Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Tuberculosis (TB) Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Tuberculosis (TB) Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Tuberculosis (TB) Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Tuberculosis (TB) Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Tuberculosis (TB) Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Tuberculosis (TB) Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Tuberculosis (TB) Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Tuberculosis (TB) Diagnostics Picture
Figure 2. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type in 2021
Figure 3. Culture-Based Diagnostics
Figure 4. Sputum Smear Microscopy
Figure 5. Rapid Molecular Diagnostics
Figure 6. Others
Figure 7. Tuberculosis (TB) Diagnostics Revenue Market Share by Application in 2021
Figure 8. Diagnostic Laboratories Picture
Figure 9. Hospitals Picture
Figure 10. Global Tuberculosis (TB) Diagnostics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Tuberculosis (TB) Diagnostics Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2017-2028)
Figure 13. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region in 2021
Figure 14. North America Tuberculosis (TB) Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Tuberculosis (TB) Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Tuberculosis (TB) Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Tuberculosis (TB) Diagnostics Market Drivers
Figure 20. Tuberculosis (TB) Diagnostics Market Restraints
Figure 21. Tuberculosis (TB) Diagnostics Market Trends
Figure 22. Danaher Recent Developments and Future Plans
Figure 23. Roche Recent Developments and Future Plans
Figure 24. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 25. BD Recent Developments and Future Plans
Figure 26. Abbott Recent Developments and Future Plans
Figure 27. Hologic Recent Developments and Future Plans
Figure 28. Qiagen Recent Developments and Future Plans
Figure 29. BioMerieux Recent Developments and Future Plans
Figure 30. Hain Lifescience Recent Developments and Future Plans
Figure 31. Oxford Immunotec Recent Developments and Future Plans
Figure 32. Global Tuberculosis (TB) Diagnostics Revenue Share by Players in 2021
Figure 33. Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 34. Global Top 3 Players Tuberculosis (TB) Diagnostics Revenue Market Share in 2021
Figure 35. Global Top 10 Players Tuberculosis (TB) Diagnostics Revenue Market Share in 2021
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 37. Global Tuberculosis (TB) Diagnostics Revenue Share by Type in 2021
Figure 38. Global Tuberculosis (TB) Diagnostics Market Share Forecast by Type (2023-2028)
Figure 39. Global Tuberculosis (TB) Diagnostics Revenue Share by Application in 2021
Figure 40. Global Tuberculosis (TB) Diagnostics Market Share Forecast by Application (2023-2028)
Figure 41. North America Tuberculosis (TB) Diagnostics Sales Market Share by Type (2017-2028)
Figure 42. North America Tuberculosis (TB) Diagnostics Sales Market Share by Application (2017-2028)
Figure 43. North America Tuberculosis (TB) Diagnostics Revenue Market Share by Country (2017-2028)
Figure 44. United States Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Tuberculosis (TB) Diagnostics Sales Market Share by Type (2017-2028)
Figure 48. Europe Tuberculosis (TB) Diagnostics Sales Market Share by Application (2017-2028)
Figure 49. Europe Tuberculosis (TB) Diagnostics Revenue Market Share by Country (2017-2028)
Figure 50. Germany Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Tuberculosis (TB) Diagnostics Sales Market Share by Type (2017-2028)
Figure 56. Asia-Pacific Tuberculosis (TB) Diagnostics Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2017-2028)
Figure 58. China Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South Korea Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Tuberculosis (TB) Diagnostics Sales Market Share by Type (2017-2028)
Figure 65. South America Tuberculosis (TB) Diagnostics Sales Market Share by Application (2017-2028)
Figure 66. South America Tuberculosis (TB) Diagnostics Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East and Africa Tuberculosis (TB) Diagnostics Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa Tuberculosis (TB) Diagnostics Sales Market Share by Application (2017-2028)
Figure 71. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue Market Share by Country (2017-2028)
Figure 72. Turkey Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. UAE Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
